Sledovať
Mutasem Taha
Mutasem Taha
Professor of Drug Design, University of Jordan
Overená e-mailová adresa na: ju.edu.jo - Domovská stránka
Názov
Citované v
Citované v
Rok
Degradability of chitosan micro/nanoparticles for pulmonary drug delivery
N Islam, I Dmour, MO Taha
Heliyon 5, e01684, 2019
2472019
Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine
I Al-masri, KM Mohammad, MO Taha
journal of enzyme inhibition and medicinal chemistry 24 (5), 1061-1066, 2009
2302009
Comprehensive structural and molecular comparison of spike proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and their interactions with ACE2
MM Hatmal, W Alshaer, MAI Al-Hatamleh, M Hatmal, O Smadi, MO Taha, ...
Cells 9 (12), 2638, 2020
2082020
Synthesis of chitosan succinate and chitosan phthalate and their evaluation as suggested matrices in orally administered, colon‐specific drug delivery systems
K Aiedeh, MO Taha
Archiv der pharmazie: an international journal pharmaceutical and medicinal …, 1999
1791999
Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral …
K Aiedeh, MO Taha
European Journal of Pharmaceutical Sciences 13 (2), 159-168, 2001
1342001
Stable Chitosan-Based Nanoparticles Using Polyphosphoric Acid or Hexametaphosphate for Tandem Ionotropic/Covalent Crosslinking and Subsequent Investigation as Novel Vehicles …
R Saeed, I Dmour, M Taha
Frontiers in Bioengineering and Biotechnology, 2020
1262020
Pharmacophore modeling, quantitative structure–activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3β inhibitory activities for …
MO Taha, Y Bustanji, MAS Al-Ghussein, M Mohammad, H Zalloum, ...
Journal of medicinal chemistry 51 (7), 2062-2077, 2008
1212008
Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation
Y Bustanji, MO Taha, IM Almasri, MAS Al-Ghussein, MK Mohammad, ...
Journal of enzyme inhibition and medicinal chemistry 24 (3), 771-778, 2009
1152009
Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis
MA Abbas, MO Taha, AM Disi, M Shomaf
European journal of pharmacology 715 (1-3), 72-75, 2013
1142013
Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening
MO Taha, Y Bustanji, AG Al-Bakri, AM Yousef, WA Zalloum, IM Al-Masri, ...
Journal of Molecular Graphics and Modelling 25 (6), 870-884, 2007
1092007
Sodium lauryl sulfate impedes drug release from zinc-crosslinked alginate beads: Switching from enteric coating release into biphasic profiles
MO Taha, W Nasser, A Ardakani, HS AlKhatib
International Journal of Pharmaceutics 350 (1-2), 291-300, 2008
902008
Enhanced drug encapsulation and extended release profiles of calcium–alginate nanoparticles by using tannic acid as a bridging cross-linking agent
SR Abulateefeh, MO Taha
Journal of microencapsulation 32 (1), 96-105, 2015
882015
Investigation of the active constituents of Portulaca oleraceae L.(Portulacaceae) growing in Jordan
AN Rasheed, FU Afifi, M Shaedah, MO Taha
Pakistan Journal of Pharmaceutical Sciences 17 (1), 37-45, 2004
872004
Docking-based comparative intermolecular contacts analysis as new 3-D QSAR concept for validating docking studies and in silico screening: NMT and GP inhibitors as case studies
MO Taha, M Habash, Z Al-Hadidi, A Al-Bakri, K Younis, S Sisan
Journal of chemical information and modeling 51 (3), 647-669, 2011
862011
Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening
IM Al‐masri, MK Mohammad, MO Taha
ChemMedChem: Chemistry Enabling Drug Discovery 3 (11), 1763-1779, 2008
822008
Combining ligand-based pharmacophore modeling, quantitative structure− activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive …
MO Taha, LA Dahabiyeh, Y Bustanji, H Zalloum, S Saleh
Journal of medicinal chemistry 51 (20), 6478-6494, 2008
822008
Elaborate ligand-based pharmacophore exploration and QSAR analysis guide the synthesis of novel pyridinium-based potent β-secretase inhibitory leads
A Al-Nadaf, GA Sheikha, MO Taha
Bioorganic & medicinal chemistry 18 (9), 3088-3115, 2010
802010
Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening
MO Taha, N Atallah, AG Al-Bakri, C Paradis-Bleau, H Zalloum, KS Younis, ...
Bioorganic & medicinal chemistry 16 (3), 1218-1235, 2008
762008
Natural and semisynthetic polymers in pharmaceutical nanotechnology
I Dmour, MO Taha
Organic materials as smart nanocarriers for drug delivery, 35-100, 2018
752018
Pharmacophore Modeling, Quantitative Structure−Activity Relationship Analysis, and Shape-Complemented in Silico Screening Allow Access to Novel Influenza …
AM Abu Hammad, MO Taha
Journal of chemical information and modeling 49 (4), 978-996, 2009
732009
Systém momentálne nemôže vykonať operáciu. Skúste to neskôr.
Články 1–20